학술논문

림프구활성화시험으로 확인된 methazolamide에 의한 독성표피괴사융해 1예
Methazolamide-induced toxic epidermal necrolysis confirmed by lymphocyte activation test
Document Type
Article
Source
Allergy asthma & respiratory disease. Jul 30, 2016 4(4):301
Subject
Methazolamide
Toxic epidermal necrolysis
Lymphocyte activation
Language
Korean
ISSN
2288-0402
Abstract
Among various dermatological entities, toxic epidermal necrolysis (TEN) is a rare but potentially fatal delayed hypersensitivity reaction to numerous medications. A 38-year-old male presented with systemic hypersensitivity reaction, such as high fever, pain in the eyes, and diffuse pruritic erythematous maculopapular eruptions with multiple targetoid plaques that became vesicular and bullous. Oral mucosa and conjunctivae were involved. The first sign appeared about 1 week after taking methazolamide (50 mg twice a day) for the management of glaucomatous eyes. Although methazolamide was discontinued, blistering and skin denudation progressed to affect up to 80% of the body surface area and a positive Nikolsky sign was noted. High fever also persisted. Skin lesions started to improve after 2 weeks of management and fever subsided. Cutaneous lesions improved with minimal permanent sequele 2 months later. HLA-B*5901 was found by high-resolution genotyping. The lymphocyte activation test performed 6 months after r mission showed a positive response to methazolamide challenge. This is the first case of methazolamide-induced TEN in which methazolamide was confirmed as a culprit drug by the lymphocyte activation test. (Allergy Asthma Respir Dis 2016:4:301-304)